Unfortunately, there is very little information about the outcomes of SARS-CoV-2 infection in patients with PC. PC was the second most frequent solid tumour in the CCC19 study (15%), but the 152 patients with PC were not evaluated separately, and there are no data concerning their disease stage or treatment [3]. Furthermore, although the UKCCMP study included 78 patients with male genital organ cancers, they were not specifically analysed [4].